Key result
Universal non-fasting total cholesterol screening in children aged 9-11 years identified a 0.9% prevalence of hypercholesterolaemia (95% CI 0.5-1.4).
Why the study?
Hypercholesterolaemia often begins in childhood, where early diagnosis and management may reduce the risk of early cardiovascular disease, motivating an evaluation of universal dyslipidemia screening in children aged 9–11 years.
Does universal non-fasting TC screening effectively detect hypercholesterolaemia in children aged 9-11 years?
Population
532 children aged 9–11 years (279 girls and 253 boys)
Design
Observational descriptive cross-sectional study
Authors
Loading...
Low yield from universal screening cautions against broad implementation; leaves open whether targeted strategies outperform population approaches in children.
Cross-Sectional (n=532)
Does universal non-fasting TC screening effectively detect hypercholesterolaemia in children aged 9-11 years?
Universal non-fasting total cholesterol screening in children aged 9-11 years is effective in detecting hypercholesterolaemia, identifying cases that might be missed by selective screening based on family history alone.
Ibrahim et al. (2023) conducted a cross-sectional in Hypercholesterolaemia (n=532). Universal non-fasting total cholesterol screening was evaluated on Prevalence of hypercholesterolaemia (TC ≥200 mg/dl) (95% CI 0.5-1.4). Universal non-fasting total cholesterol screening in children aged 9-11 years identified a 0.9% prevalence of hypercholesterolaemia (95% CI 0.5-1.4).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: